Constitutional mutations of the CHEK2 gene are a risk factor for MDS, but not for de novo AML

In conclusion, the congenital CHEK2 inactivation is strongly associated with the risk of MDS and with a poorer prognosis of the disease. However, the chromosomal instability in AML is not correlated with the hereditary dysfunction of CHEK2.